{
    "organizations": [],
    "uuid": "dc16353a5f5f1f8d50364a4a00f33db273cf1a78",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-ssy-group-unit-entered-agreement-w/brief-ssy-group-unit-entered-agreement-with-zhengzhou-university-for-research-of-new-liver-fibrosis-drug-idUSFWN1QN0GY",
    "ord_in_thread": 0,
    "title": "BRIEF-Ssy Group Unit ‍Entered Agreement With Zhengzhou University For Research Of New Liver Fibrosis​ Drug",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "March 5 (Reuters) - Ssy Group Ltd:\n* UNIT ‍ENTERED AGREEMENT WITH ZHENGZHOU UNIVERSITY IN RELATION TO RESEARCH AND DEVELOPMENT OF NEW DRUG USED FOR LIVER FIBROSIS​\n* ‍ AGGREGATE INVESTMENT IN RESEARCH AND DEVELOPMENT OF DRUG FOR TREATMENT OF LIVER FIBROSIS​ IS RMB 50 MILLION Source text for Eikon: Further company coverage:\n ",
    "published": "2018-03-05T20:21:00.000+02:00",
    "crawled": "2018-03-06T22:19:54.015+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "march",
        "reuters",
        "ssy",
        "group",
        "ltd",
        "unit",
        "agreement",
        "zhengzhou",
        "university",
        "relation",
        "research",
        "development",
        "new",
        "drug",
        "used",
        "liver",
        "aggregate",
        "investment",
        "research",
        "development",
        "drug",
        "treatment",
        "liver",
        "rmb",
        "million",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}